Editorial
Welcome to the first homepage edition of i2P for 2012.
In many ways it has been a slow start to the New Year because of having to deal with the “leftovers” from 2011.
One of those items for i2P was that a third-party provider to the site did not advise of a code change to the security section in our subscribe panel, creating a range of frustrated subscribers not able to get on board.
We apologise to all those potential subscribers who were unable to register with us in the second half of 2011, but if you try once more you should have no problem.
Columns
Rollo Manning: Pharma-Goss
Linda Bryant: Inside NZ
Loretta Marron BSc: Health Watch
Barry Urquhart: Marketing Focus
Mark Neuenschwander: I`ve been thinking about...Recent Comments
Past Editions
Volume 1 Number 1
Volume 1 Number 2
Volume 1 Number 3
Volume 1 Number 4
Volume 1 Number 5
Volume 1 Number 6
Volume 1 Number 7
Volume 2 Number 1
Volume 2 Number 2
Volume 2 Number 3
Volume 2 Number 4
Volume 2 Number 5
Volume 2 Number 6
Volume 2 Number 7
Volume 2 Number 8
Volume 2 Number 9
Volume 2 Number 10
Volume 2 Number 11
Volume 3 Number 1
Volume 3 Number 2
Volume 3 Number 3
Volume 3 Number 4
Volume 3 Number 5
Volume 3 Number 6
Volume 3 Number 7
Volume 3 Number 8
Volume 3 Number 9
Volume 3 Number 10
Volume 3 Number 11
Volume 2012 Number 1
Health Politics
Neil Johnston: Friends of Science in Medicine
Peter Sayers: Confessions of a Frustrated Pharmacist
James Ellerson: $75.5 million in 5CPA lying idle. Why is it so?EPublications
Contribute
i2P.com.au welcomes unsolicited contributions from interested persons.
The best way to pitch ideas and submit articles is by email to: neilj@computachem.com.au.
Include your name, contact details, a short profile and an author headshot (75 x 75 pixels, jpeg file).
Please help us cut down on editing time by submitting articles in MS Word.
Copyright remains with the author, and articles may be reproduced elsewhere but we ask that i2P.com.au is attributed with first publication.
You must warrant that your work is original, has not been published elsewhere (including online), does not breach copyright nor defame any person.
i2P.com.au will not publish material that is untrue, seeks to defame or unnecessarily distorts an issue.
We seek submissions on political and social issues in Australian Pharmacy and the world - writing that is witty not whingeing, independent not ideological, brave not bland.
Pitches for articles are welcome.
Unsolicited pieces can be submitted to a maximum length of 1200 words, an ideal length being 600-800 words.
Illustrators and cartoonists are also encouraged to submit their work.
Avoid jargon, dot points, numbered paragraphs and unexplained acronyms.
Please provide hyperlinks to any documents, media reports or websites to which the article refers.
NO footnotes, but please provide references as links or citations.
Please assume you are writing for a non-expert but engaged readership, here and overseas.
A short biographical note should be included. Anonymity, if essential, will be protected.
Suggestions for illustrations are welcome.
Research Reports
Dr Andrew Byrne & Associates: Tranquillizer use rife amongst OTP subjects world-wide, most legally prescribedPractice Development
Neil Retallick: Are the discounters impacting community pharmacy beyond margin erosion? | open full screen
Kay Dunkley - BPharm, Grad Dip Hosp Pharm, Grad Dip Health Admin, MPS, MSHPA: Support services for pharmacists and doctors in the United Kingdom – Part 3 Royal Medical Benevolent Fund | open full screen
Staff Writer: Catch the early wave in 2012 and secure your valuable CPD Credits at the Guild Pharmacy Academy – NSW Convention | open full screen
Information Technology
Dr David More: Australian Health Information Technology LinksIndigenous Health
Preventive Medicine
Gerald Quigley: It’s Time!If any difficulty is found in subscribing, please use the "Contact Us" panel found in the navigation bar with the message "subscribe" and your email address.
